A nomogram including admission serum glycated albumin/albumin ratio to predict mortality in patients with severe fever with thrombocytopenia syndrome.
Clinical outcome
Glycated albumin/albumin ratio
Nomogram
Prediction
Severe fever with thrombocytopenia syndrome
Journal
BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551
Informations de publication
Date de publication:
23 Aug 2024
23 Aug 2024
Historique:
received:
20
09
2023
accepted:
12
08
2024
medline:
24
8
2024
pubmed:
24
8
2024
entrez:
23
8
2024
Statut:
epublish
Résumé
Severe fever with thrombocytopenia syndrome (SFTS) is a novel tick-borne infectious disease with a high fatality rate. Although several nomograms based on demographic and laboratory data have been reported to predict the prognosis of SFTS in recent studies, baseline serum glycated albumin (GA)/albumin (ALB) ratio included risk model has not been evaluated for the prediction of clinical outcome. A total of 214 SFTS patients with integral data admitted to our hospital from May, 2020 to November, 2022 were included in this study. SFTS infection was confirmed by real time fluorescent quantitative PCR (qRT-PCR). The demographic characteristics, clinical and laboratory data were collected with in 24 h of admission and 1 to 2 days before discharge and were analysed retrospectively. Fiffty-seven patients (26.6%) died. Multivariate logistic regression analysis showed that age, aspartate aminotransferase (AST), blood glucose (GLU), GA/ALB ratio, neutrophil counts (NEU) and lymphocyte percentage (LYM%) were the independent risk factors for mortality. A nomogram by these factors was created using RMS package in the R program. Area under the receiver operating characteristic (ROC) curve (AUC) of this nomogram was 0.88 (95% CI: 0.83, 0.93). This model showed the excellent net benefit, as revealed by the decision curve analysis. GA/ALB ratios were also independent risk factors for poor out clinical come in subgroups of patients with hyperglycemia on admission and with diabetes history. Nomograms were constructed by the independent risk factors in the subgroups. AUCs of the nomograms in the subgroups showed high predictive values for adverse prognosis. GA/ALB ratios were independent risk factors for mortality in all SFTS patients and subgroups of with hyperglycemia on admission and diabetes history. The nomograms including GA/ALB ratio had high predictive value for adverse clinical outcome.The nomograms provide a basis for clinical decision-making for the treatment of SFTS patients in different clinical settings.
Sections du résumé
BACKGROUND
BACKGROUND
Severe fever with thrombocytopenia syndrome (SFTS) is a novel tick-borne infectious disease with a high fatality rate. Although several nomograms based on demographic and laboratory data have been reported to predict the prognosis of SFTS in recent studies, baseline serum glycated albumin (GA)/albumin (ALB) ratio included risk model has not been evaluated for the prediction of clinical outcome.
METHODS
METHODS
A total of 214 SFTS patients with integral data admitted to our hospital from May, 2020 to November, 2022 were included in this study. SFTS infection was confirmed by real time fluorescent quantitative PCR (qRT-PCR). The demographic characteristics, clinical and laboratory data were collected with in 24 h of admission and 1 to 2 days before discharge and were analysed retrospectively.
RESULTS
RESULTS
Fiffty-seven patients (26.6%) died. Multivariate logistic regression analysis showed that age, aspartate aminotransferase (AST), blood glucose (GLU), GA/ALB ratio, neutrophil counts (NEU) and lymphocyte percentage (LYM%) were the independent risk factors for mortality. A nomogram by these factors was created using RMS package in the R program. Area under the receiver operating characteristic (ROC) curve (AUC) of this nomogram was 0.88 (95% CI: 0.83, 0.93). This model showed the excellent net benefit, as revealed by the decision curve analysis. GA/ALB ratios were also independent risk factors for poor out clinical come in subgroups of patients with hyperglycemia on admission and with diabetes history. Nomograms were constructed by the independent risk factors in the subgroups. AUCs of the nomograms in the subgroups showed high predictive values for adverse prognosis.
CONCLUSIONS
CONCLUSIONS
GA/ALB ratios were independent risk factors for mortality in all SFTS patients and subgroups of with hyperglycemia on admission and diabetes history. The nomograms including GA/ALB ratio had high predictive value for adverse clinical outcome.The nomograms provide a basis for clinical decision-making for the treatment of SFTS patients in different clinical settings.
Identifiants
pubmed: 39179974
doi: 10.1186/s12879-024-09752-9
pii: 10.1186/s12879-024-09752-9
doi:
Substances chimiques
Serum Albumin
0
Glycated Serum Albumin
0
Glycation End Products, Advanced
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
858Informations de copyright
© 2024. The Author(s).
Références
Seo JW, Kim D, Yun N, Kim DM. Clinical update of severe fever with Thrombocytopenia Syndrome. Viruses. 2021;13(7):1213. https://doi.org/10.3390/v13071213
doi: 10.3390/v13071213
pubmed: 34201811
pmcid: 8310018
Li S, Li Y, Wang Q, Yu X, Liu M, Xie H, et al. Multiple organ involvement in severe fever with thrombocytopenia syndrome: an immunohistochemical finding in a fatal case. Virol J. 2018;15(1):97. https://doi.org/10.1186/s12985-018-1006-7
doi: 10.1186/s12985-018-1006-7
pubmed: 29848330
pmcid: 5977472
Chen R, Li Q, Chen H, Yang H, Wei X, Chen M, et al. Severe fever with thrombocytopenia syndrome virus replicates in brain tissues and damages neurons in newborn mice. BMC Microbiol. 2022;22(1):204. https://doi.org/10.1186/s12866-022-02609-8
doi: 10.1186/s12866-022-02609-8
pubmed: 35987890
pmcid: 9392058
Gao C, Yu Y, Wen C, Li Z, Ding H, Qi X, et al. Nonstructural protein NSs activates Inflammasome and Pyroptosis through Interaction with NLRP3 in human microglial cells infected with severe fever with Thrombocytopenia Syndrome Bandavirus. J Virol. 2022;96(13):e0016722. https://doi.org/10.1128/jvi.00167-22
doi: 10.1128/jvi.00167-22
pubmed: 35695505
Yang T, Huang H, Jiang L, Li J. Overview of the immunological mechanism underlying severe fever with thrombocytopenia syndrome (review). Int J Mol Med. 2022;50(3):118. https://doi.org/10.3892/ijmm.2022.5174
doi: 10.3892/ijmm.2022.5174
pubmed: 35856413
pmcid: 9333902
Khalil J, Kato H, Fujita T. The role of non-structural protein NSs in the pathogenesis of severe fever with Thrombocytopenia Syndrome. Viruses. 2021;13(5):876. https://doi.org/10.3390/v13050876
doi: 10.3390/v13050876
pubmed: 34064604
pmcid: 8151429
Kwon JS, Kim MC, Kim JY, Jeon NY, Ryu BH, Hong J, et al. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J Clin Virol. 2018;101:57–62. https://doi.org/10.1016/j.jcv.2018.01.017
doi: 10.1016/j.jcv.2018.01.017
pubmed: 29427908
pmcid: 7106421
Danielski LG, Giustina AD, Bonfante S, Barichello T, Petronilho F. The NLRP3 inflammasome and its role in Sepsis Development. Inflammation. 2020;43(1):24–31. https://doi.org/10.1007/s10753-019-01124-9 .
doi: 10.1007/s10753-019-01124-9
pubmed: 31741197
Anguizola J, Matsuda R, Barnaby OS, Hoy KS, Wa C, DeBolt E, et al. Review: glycation of human serum albumin. Clin Chim Acta. 2013;425:64–76. https://doi.org/10.1016/j.cca.2013.07.013
doi: 10.1016/j.cca.2013.07.013
pubmed: 23891854
Rabbani G, Ahn SN. Structure, enzymatic activities, glycation and therapeutic potential of human serum albumin: a natural cargo. Int J Biol Macromol. 2019;123:979–90. https://doi.org/10.1016/j.ijbiomac.2018.11.053 .
doi: 10.1016/j.ijbiomac.2018.11.053
pubmed: 30439428
Piarulli F, Banfi C, Brioschi M, Altomare A, Ragazzi E, Cosma C, et al. The Burden of impaired serum albumin antioxidant properties and Glyco-Oxidation in Coronary Heart Disease patients with and without type 2 diabetes Mellitus. Antioxid (Basel). 2022;11(8):1501. https://doi.org/10.3390/antiox11081501
doi: 10.3390/antiox11081501
Belinskaia DA, Voronina PA, Shmurak VI, Jenkins RO, Goncharov NV. Serum albumin in Health and Disease: esterase, antioxidant, Transporting and Signaling properties. Int J Mol Sci. 2021;22(19):10318. https://doi.org/10.3390/ijms221910318
doi: 10.3390/ijms221910318
pubmed: 34638659
pmcid: 8508759
Qiu H, Jin L, Chen J, Shi M, Shi F, Wang M, et al. Comprehensive Glycomic Analysis reveals that human serum albumin glycation specifically affects the Pharmacokinetics and Efficacy of different anticoagulant drugs in diabetes. Diabetes. 2020;69(4):760–70. https://doi.org/10.2337/db19-0738
doi: 10.2337/db19-0738
pubmed: 31974145
Maciążek-Jurczyk M, Szkudlarek A, Chudzik M, Pożycka J, Sułkowska A. Alteration of human serum albumin binding properties induced by modifications: a review. Spectrochim Acta Mol Biomol Spectrosc. 2018;188:675–83. https://doi.org/10.1016/j.saa.2017.05.023
doi: 10.1016/j.saa.2017.05.023
Gong L, Zhang L, Wu J, Lu S, Lyu Y, Zhu M, et al. Clinical progress and risk factors for death from severe fever with Thrombocytopenia Syndrome: a multihospital Retrospective Investigation in Anhui, China. Am J Trop Med Hyg. 2021;104(4):1425–31. https://doi.org/10.4269/ajtmh.20-0270
doi: 10.4269/ajtmh.20-0270
pubmed: 33591933
pmcid: 8045620
Ge H, Zhao J, Zhang S, Xu Y, Liu Y, Peng X, et al. Impact of glycemia and insulin treatment in fatal outcome of severe fever with thrombocytopenia syndrome. Int J Infect Dis. 2022;119:24–31. https://doi.org/10.1016/j.ijid.2022.03.038
doi: 10.1016/j.ijid.2022.03.038
pubmed: 35341999
Zhang Y, Zhang Y, Xu Y, Huang Y. The associations between fasting blood glucose levels and mortality of SFTS in patients. BMC Infect Dis. 2021;21(1):761. https://doi.org/10.1186/s12879-021-06463-3
doi: 10.1186/s12879-021-06463-3
pubmed: 34353296
pmcid: 8343909
Liu Z, Zhang R, Zhou W, Ma R, Han L, Zhao Z, et al. High levels of C-reactive protein-to-albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage. J Med Virol. 2022;94(11):5375–84. https://doi.org/10.1002/jmv.27972
doi: 10.1002/jmv.27972
pubmed: 35790466
pmcid: 9540880
Zu Z, Hu Y, Zheng X, Chen C, Zhao Y, Jin Y, et al. A ten-year assessment of the epidemiological features and fatal risk factors of hospitalised severe fever with thrombocytopenia syndrome in Eastern China. Epidemiol Infect. 2022;150:e131. https://doi.org/10.1017/S0950268822001108
doi: 10.1017/S0950268822001108
pubmed: 35726737
pmcid: 9306006
Zhang SF, Yang ZD, Huang ML, Wang ZB, Hu YY, Miao D, et al. Preexisting chronic conditions for fatal outcome among SFTS patients: an observational Cohort Study. PLoS Negl Trop Dis. 2019;13(5):e0007434. https://doi.org/10.1371/journal.pntd.0007434
doi: 10.1371/journal.pntd.0007434
pubmed: 31136581
pmcid: 6555536
Gajahi Soudahome A, Catan A, Giraud P, Assouan Kouao S, Guerin-Dubourg A, Debussche X, et al. Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide. J Biol Chem. 2018;293(13):4778–91. https://doi.org/10.1074/jbc.M117.815274
doi: 10.1074/jbc.M117.815274
pubmed: 29414771
pmcid: 5880132
Zendjabil M. Glycated albumin. Clin Chim Acta. 2020;502:240–4. https://doi.org/10.1016/j.cca.2019.11.007
doi: 10.1016/j.cca.2019.11.007
pubmed: 31734145
Khalid M, Petroianu G, Adem A. Advanced Glycation End products and Diabetes Mellitus: mechanisms and perspectives. Biomolecules. 2022;12(4):542. https://doi.org/10.3390/biom12040542 .
doi: 10.3390/biom12040542
pubmed: 35454131
pmcid: 9030615
Kravchenko IV, Furalyov VA, Popov VO. Glycated albumin stimulates expression of inflammatory cytokines in muscle cells. Cytokine. 2020;128:154991. https://doi.org/10.1016/j.cyto.2020.154991
doi: 10.1016/j.cyto.2020.154991
pubmed: 32000013
Iqbal S, Qais FA, Alam MM, Naseem I. Effect of glycation on human serum albumin-zinc interaction: a biophysical study. J Biol Inorg Chem. 2018;23(3):447–58. https://doi.org/10.1007/s00775-018-1554-8 .
doi: 10.1007/s00775-018-1554-8
pubmed: 29619544
Iles J, Zmuidinaite R, Sadee C, Gardiner A, Lacey J, Harding S, et al. SARS-CoV-2 spike protein binding of glycated serum albumin-its potential role in the pathogenesis of the COVID-19 clinical syndromes and Bias towards individuals with Pre-Diabetes/Type 2 diabetes and metabolic diseases. Int J Mol Sci. 2022;23(8):4126. https://doi.org/10.3390/ijms23084126 .
doi: 10.3390/ijms23084126
pubmed: 35456942
pmcid: 9030890
Wang L, Liu Y, Qu R, Zou Z. Serum mAST/ALT ratio had high predictive value for adverse outcome of severe fever with thrombocytopenia syndrome with severe condition. BMC Infect Dis. 2023;23(1):168. https://doi.org/10.1186/s12879-023-08121-2 .
doi: 10.1186/s12879-023-08121-2
pubmed: 36932323
pmcid: 10022549